Chuanzhen W. Lu

12 Wulumuqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China.

Journal: BMC neurology

Published: October 12, 2025

CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells.

CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells.

Journal: Frontiers in immunology

Published: September 12, 2025

Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder.

Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder.

Journal: Frontiers in immunology

Published: September 12, 2025

Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role.

Real-world experience of teriflunomide in relapsing multiple sclerosis: paramagnetic rim lesions may play a role.

Journal: Frontiers in immunology

Published: November 23, 2023

Causal associations between prodromal infection and neuromyelitis optica spectrum disorder: A Mendelian randomization study.

Causal associations between prodromal infection and neuromyelitis optica spectrum disorder: A Mendelian randomization study.

Journal: European journal of neurology

Published: April 20, 2023

The immune imbalance between follicular regulatory and helper T cells in myelin oligodendrocyte glycoprotein IgG-associated disease.

The immune imbalance between follicular regulatory and helper T cells in myelin oligodendrocyte glycoprotein IgG-associated disease.

Journal: Clinical immunology (Orlando, Fla.)

Published: March 31, 2023

Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study.

Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 07, 2022

Analysis of Pregnancy-Related Attacks in Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis.

Analysis of Pregnancy-Related Attacks in Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis.

Journal: JAMA network open

Published: August 04, 2022

Baseline retinal nerve fiber layer thickness as a predictor of multiple sclerosis progression: New insights from the FREEDOMS II study.

Baseline retinal nerve fiber layer thickness as a predictor of multiple sclerosis progression: New insights from the FREEDOMS II study.

Journal: European journal of neurology

Published: August 01, 2022

Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody.

Deep learning-based relapse prediction of neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody.

Journal: Frontiers in neurology

Published: May 19, 2022

Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder.

Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder.

Journal: European journal of neurology

Published: February 22, 2022

Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models.

Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models.

Journal: Frontiers in immunology

Published: February 11, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026